Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis

[1]  G. Saposnik,et al.  Prevalence of Fabry Disease and Outcomes in Young Canadian Patients With Cryptogenic Ischemic Cerebrovascular Events , 2017, Stroke.

[2]  L. Tavazzi,et al.  Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics. , 2016, Journal of the American College of Cardiology.

[3]  W. Shimizu,et al.  Novel α-Galactosidase A Mutation (K391E) in a Young Woman With Severe Cardiac and Renal Manifestations of Fabry Disease. , 2016, International heart journal.

[4]  M. Okumi,et al.  Kidney transplantation from a mother with unrecognized Fabry disease to her son with low α‐galactosidase A activity: A 14‐year follow‐up without enzyme replacement therapy , 2016, Nephrology.

[5]  J. Roche,et al.  Increased glycolipid storage produced by the inheritance of a complex intronic haplotype in the α-galactosidase A (GLA) gene , 2015, BMC Genetics.

[6]  J. Oliveira,et al.  Variations in the GLA gene correlate with globotriaosylceramide and globotriaosylsphingosine analog levels in urine and plasma. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[7]  C. Hollak,et al.  Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease , 2015, Journal of Medical Genetics.

[8]  A. Fellgiebel,et al.  Cerebrovascular Involvement in Fabry Disease: Current Status of Knowledge , 2015, Stroke.

[9]  P. Postema,et al.  Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance. , 2014, International journal of cardiology.

[10]  C. Hollak,et al.  A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance , 2013, Journal of Medical Genetics.

[11]  K. Lackner,et al.  Functional Characterisation of Alpha-Galactosidase A Mutations as a Basis for a New Classification System in Fabry Disease , 2013, PLoS genetics.

[12]  T. Fujii,et al.  Japanese patients with Fabry disease predominantly showing cardiac and neurological manifestation with novel missense mutation: R220P. , 2013, Journal of cardiology.

[13]  I. Narita,et al.  Screening of male dialysis patients for fabry disease by plasma globotriaosylsphingosine. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[14]  H. Oda,et al.  Renal transplantation between siblings with unrecognized Fabry disease. , 2013, Transplantation proceedings.

[15]  Y. Chien,et al.  Fabry Disease: Incidence of the Common Later-Onset α-Galactosidase A IVS4+919G→A Mutation in Taiwanese Newborns—Superiority of DNA-Based to Enzyme-Based Newborn Screening for Common Mutations , 2012, Molecular medicine.

[16]  A. Pisani,et al.  A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report , 2012, BMC Cardiovascular Disorders.

[17]  T. Kanekura,et al.  Fabry disease: biochemical, pathological and structural studies of the α-galactosidase A with E66Q amino acid substitution. , 2012, Molecular genetics and metabolism.

[18]  M. Lipinski,et al.  Female with Fabry Disease Unknowingly Donates Affected Kidney to Sister: A Call for Pre-transplant Genetic Testing. , 2011, JIMD reports.

[19]  M. Kaps,et al.  Frequency of Fabry disease in patients with small‐fibre neuropathy of unknown aetiology: a pilot study , 2011, European journal of neurology.

[20]  B. Winchester,et al.  Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group , 2011, Journal of Inherited Metabolic Disease.

[21]  A. Zwinderman,et al.  Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease. , 2010, Biochimica et biophysica acta.

[22]  T. Kitagawa,et al.  Plasma globotriaosylsphingosine as a biomarker of Fabry disease. , 2010, Molecular genetics and metabolism.

[23]  P. Elliott,et al.  Natural course of Fabry disease: changing pattern of causes of death in FOS – Fabry Outcome Survey , 2009, Journal of Medical Genetics.

[24]  R. Brady,et al.  Elevated globotriaosylsphingosine is a hallmark of Fabry disease , 2008, Proceedings of the National Academy of Sciences.

[25]  J. Miyazaki,et al.  Novel mutations of the GLA gene in Japanese patients with Fabry disease and their functional characterization by active site specific chaperone , 2008, Human mutation.

[26]  Y. Eto,et al.  Clinical manifestations and natural history of Japanese heterozygous females with Fabry disease , 2008, Journal of Inherited Metabolic Disease.

[27]  C. A. Fossati,et al.  A successful approach for the detection of Fabry patients in Argentina , 2006, Clinical genetics.

[28]  Y. Eto,et al.  Significance of screening for Fabry disease among male dialysis patients , 2005, Clinical and Experimental Nephrology.

[29]  C. Hollak,et al.  Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[30]  C. Eng,et al.  Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype. , 2003, Kidney international.

[31]  R. Desnick,et al.  Fabry disease: 45 novel mutations in the α-galactosidase A gene causing the classical phenotype , 2002 .

[32]  R. Desnick,et al.  Fabry disease: 45 novel mutations in the alpha-galactosidase A gene causing the classical phenotype. , 2002, Molecular Genetics and Metabolism.

[33]  R. Desnick.  α-Galactosidase A deficiency. Fabry disease , 2001 .

[34]  C. Eng,et al.  Fabry Disease: Thirty-Five Mutations in the α-Galactosidase A Gene in Patients with Classic and Variant Phenotypes , 1997, Molecular medicine.

[35]  R. Wevers,et al.  Uneven X inactivation in a female monozygotic twin pair with Fabry disease and discordant expression of a novel mutation in the alpha-galactosidase A gene. , 1996, Journal of medical genetics.

[36]  H. Sakuraba,et al.  An atypical variant of Fabry's disease in men with left ventricular hypertrophy. , 1995, The New England journal of medicine.

[37]  C. Eng,et al.  Fabry disease: twenty-three mutations including sense and antisense CpG alterations and identification of a deletional hot-spot in the alpha-galactosidase A gene. , 1994, Human molecular genetics.

[38]  R. Desnick,et al.  Identification of point mutations in the alpha-galactosidase A gene in classical and atypical hemizygotes with Fabry disease. , 1990, American journal of human genetics.

[39]  R. Brady,et al.  Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. , 1967, The New England journal of medicine.

[40]  H. Klepzig.  [The department of cardiology]. , 1957, Die Medizinische.